Cargando…

Topical Application of Temperature-Sensitive Gel Containing Caerin 1.1 and 1.9 Peptides on TC-1 Tumour-Bearing Mice Induced High-Level Immune Response in the Tumour Microenvironment

The development of topical cream drugs that increase the immune activation of tumour-infiltrating lymphocytes against tumour and chronic viral infection-associated lesions is of great immunotherapeutic significance. This study demonstrates that the topical application of a temperature-sensitive gel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Guoying, Liu, Xiaosong, Li, Hejie, Fogarty, Conor E., Chen, Shu, Zhang, Pingping, Liu, Ying, Wu, Xiaolian, Wei, Ming Q., Chen, Guoqiang, Zhang, Ping, Wang, Tianfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632150/ https://www.ncbi.nlm.nih.gov/pubmed/34858827 http://dx.doi.org/10.3389/fonc.2021.754770

Ejemplares similares

Intratumoral injection of caerin 1.1 and 1.9 peptides increases the efficacy of vaccinated TC‐1 tumor‐bearing mice with PD‐1 blockade by modulating macrophage heterogeneity and the activation of CD8(+) T cells in the tumor microenvironment
por: Ni, Guoying, et al.
Publicado: (2021)

Caerin 1.1/1.9 Enhances Antitumour Immunity by Activating the IFN-α Response Signalling Pathway of Tumour Macrophages
por: Yang, Xiaodan, et al.
Publicado: (2022)

Caerin 1.1 and 1.9 Peptides from Australian Tree Frog Inhibit Antibiotic-Resistant Bacteria Growth in a Murine Skin Infection Model
por: Chen, Shu, et al.
Publicado: (2021)

Preclinical Pharmacokinetics, Biodistribution, and Acute Toxicity Evaluation of Caerin 1.9 Peptide in Sprague Dawley Rats
por: Yang, Xiaodan, et al.
Publicado: (2022)

Caerin 1 Peptides, the Potential Jack-of-All-Trades for the Multiple Antibiotic-Resistant Bacterial Infection Treatment and Cancer Immunotherapy
por: Xiao, Liyin, et al.
Publicado: (2022)

(131)I-Caerin 1.1 and (131)I-Caerin 1.9 for the treatment of non-small-cell lung cancer
por: Liu, Na, et al.
Publicado: (2022)

Comparative Proteomic Study of the Antiproliferative Activity of Frog Host-Defence Peptide Caerin 1.9 and Its Additive Effect with Caerin 1.1 on TC-1 Cells Transformed with HPV16 E6 and E7
por: Ni, Guoying, et al.
Publicado: (2018)

Host-Defense Peptides Caerin 1.1 and 1.9 Stimulate TNF-Alpha-Dependent Apoptotic Signals in Human Cervical Cancer HeLa Cells
por: Ni, Guoying, et al.
Publicado: (2020)

Single-nucleus RNA sequencing and deep tissue proteomics reveal distinct tumour microenvironment in stage-I and II cervical cancer
por: Liu, Xiaosong, et al.
Publicado: (2023)

Targeted radioimmunotherapy with the iodine-131-labeled caerin 1.1 peptide for human anaplastic thyroid cancer in nude mice
por: Lin, Ruoting, et al.
Publicado: (2021)

The Dosage of the Derivative of Clostridium Ghonii (DCG) Spores Dictates Whether an IFNγ/IL-9 or a Strong IFNγ Response Is Elicited in TC-1 Tumour Bearing Mice
por: Ni, Guoying, et al.
Publicado: (2019)

Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis
por: Lin, Ruoting, et al.
Publicado: (2021)

Synthesized natural peptides from amphibian skin secretions increase the efficacy of a therapeutic vaccine by recruiting more T cells to the tumour site
por: Pan, Xuan, et al.
Publicado: (2019)

Caerin1.1 Suppresses the Growth of Porcine Epidemic Diarrhea Virus In Vitro via Direct Binding to the Virus
por: Guo, Nan, et al.
Publicado: (2018)

Caerin 1 Antimicrobial Peptides that Inhibit HIV and Neisseria May Spare Protective Lactobacilli
por: Rollins-Smith, Louise A., et al.
Publicado: (2020)

Tumour angiogenesis is reduced in the Tc1 mouse model of Down Syndrome
por: Reynolds, Louise E., et al.
Publicado: (2010)

Interleukin-1 production by immunologically hyporeactive tumour-bearing mice.
por: Holán, V., et al.
Publicado: (1990)

Going Beyond Host Defence Peptides: Horizons of Chemically Engineered Peptides for Multidrug-Resistant Bacteria
por: Cavallazzi Sebold, Bernardo, et al.
Publicado: (2023)

Comment on Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats
por: Alamdari, Nima, et al.
Publicado: (2012)

Human papillomavirus infection among head and neck squamous cell carcinomas in southern China
por: Ni, Guoying, et al.
Publicado: (2019)

Comparative proteomic study reveals the enhanced immune response with the blockade of interleukin 10 with anti-IL-10 and anti-IL-10 receptor antibodies in human U937 cells
por: Ni, Guoying, et al.
Publicado: (2019)

Expression of tumour transcription factor GLI1 in canine mammary tumours tissue
por: Liu, Penggang, et al.
Publicado: (2022)

Presence and significance of tumour cells in the spleen of tumour-bearing hamsters.
por: Zuinghedau, J., et al.
Publicado: (1979)

Ganoderma triterpenoids attenuate tumour angiogenesis in lung cancer tumour-bearing nude mice
por: Liu, Wei, et al.
Publicado: (2020)

Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats: a role in impaired regeneration?
por: Toledo, Míriam, et al.
Publicado: (2011)

The Significance of Splenomegaly in Tumour-Bearing Mice
por: Woodruff, M. F. A., et al.
Publicado: (1962)

Roles of Farnesyl-Diphosphate Farnesyltransferase 1 in Tumour and Tumour Microenvironments
por: Ha, Nguyen Thi, et al.
Publicado: (2020)

Potentiation of tumour growth by endotoxin in serum from syngeneic tumour-bearing mice.
por: Kearney, R., et al.
Publicado: (1980)

HIF-1 and tumour radiosensitivity
por: Moeller, B J, et al.
Publicado: (2006)

Diagnostic utility of Wilms’ tumour-1 protein (WT-1) immunostaining in paediatric renal tumours
por: Goyal, Surbhi, et al.
Publicado: (2016)

Blood Amino Nitrogen in Tumour-bearing Mice
por: Mehairy, M. M. El
Publicado: (1950)

The metabolic response of tumour-bearing mice to fasting.
por: Rofe, A. M., et al.
Publicado: (1985)

Proceedings: Metabolic abnormalities in tumour bearing animals.
por: Calman, K. C., et al.
Publicado: (1975)

Humoral mediation for cachexia in tumour-bearing rats.
por: Tessitore, L., et al.
Publicado: (1993)

Metabolism of Serum Albumin in Tumour-Bearing Rats
por: Hradec, J.
Publicado: (1958)

Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor.
por: Trentin, L., et al.
Publicado: (1995)

Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis
por: Li, Hongjun, et al.
Publicado: (2021)

Expression of p53 in urothelial cell cultures from tumour-bearing and tumour-free patients.
por: Harney, J., et al.
Publicado: (1995)

On the Failure of Tumour Homogenate Injections to Simulate Quantitatively the Changes in Catalase Activity in the Tumour-bearing host
por: Adams, D. H.
Publicado: (1961)

Pathology of Tumours in Laboratory Animals Vol. 1.—Tumours of the Rat, Part 2
por: Butler, W. H.
Publicado: (1978)

Cannot write session to /tmp/vufind_sessions/sess_8o187ju8a5kev7mp6plgke9qvt